ifosfamide has been researched along with Hypertension in 3 studies
Hypertension: Persistently high systemic arterial BLOOD PRESSURE. Based on multiple readings (BLOOD PRESSURE DETERMINATION), hypertension is currently defined as when SYSTOLIC PRESSURE is consistently greater than 140 mm Hg or when DIASTOLIC PRESSURE is consistently 90 mm Hg or more.
| Excerpt | Relevance | Reference |
|---|---|---|
| " Nephrotoxicity is a known side effect of several treatments, including cisplatin, carboplatin, ifosfamide, radiotherapy and nephrectomy, and can cause glomerular filtration rate (GFR) impairment, proteinuria, tubulopathy, and hypertension." | 5.01 | Early and late adverse renal effects after potentially nephrotoxic treatment for childhood cancer. ( Bökenkamp, A; Kooijmans, EC; Tettero, JM; Tjahjadi, NS; van der Pal, HJ; van Dulmen-den Broeder, E; Veening, MA, 2019) |
| " Nephrotoxicity is one of these known (acute) side effects of several treatments, including cisplatin, carboplatin, ifosfamide, radiotherapy and nephrectomy, and can cause glomerular filtration rate impairment, proteinuria, tubulopathy and hypertension." | 4.89 | Early and late renal adverse effects after potentially nephrotoxic treatment for childhood cancer. ( Blufpand, H; Bökenkamp, A; Jaspers, MW; Knijnenburg, SL; Kremer, LC; Mulder, RL; Schouten-Van Meeteren, AY; van Dulmen-den Broeder, E; Veening, MA, 2013) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Schiavetti, A | 1 |
| Pedetti, V | 1 |
| Varrasso, G | 1 |
| Marrucci, O | 1 |
| Celani, C | 1 |
| Andreoli, G | 1 |
| Bonci, E | 1 |
| Kooijmans, EC | 1 |
| Bökenkamp, A | 2 |
| Tjahjadi, NS | 1 |
| Tettero, JM | 1 |
| van Dulmen-den Broeder, E | 2 |
| van der Pal, HJ | 1 |
| Veening, MA | 2 |
| Knijnenburg, SL | 1 |
| Mulder, RL | 1 |
| Schouten-Van Meeteren, AY | 1 |
| Blufpand, H | 1 |
| Kremer, LC | 1 |
| Jaspers, MW | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Efficacy of Oral Supplementation With Magnesium to Reduce Febrile Neutropenia in Pediatric Oncology Patients Treated With Cisplatin-Based Chemotherapy: Randomized Clinical Trial[NCT03449693] | Phase 2 | 214 participants (Anticipated) | Interventional | 2017-10-19 | Recruiting | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
2 reviews available for ifosfamide and Hypertension
| Article | Year |
|---|---|
Early and late adverse renal effects after potentially nephrotoxic treatment for childhood cancer.
Topics: Adult; Antineoplastic Agents; Carboplatin; Child; Cisplatin; Glomerular Filtration Rate; Humans; Hyp | 2019 |
Early and late renal adverse effects after potentially nephrotoxic treatment for childhood cancer.
Topics: Adult; Antineoplastic Agents; Carboplatin; Child; Cisplatin; Glomerular Filtration Rate; Humans; Hyp | 2013 |
1 trial available for ifosfamide and Hypertension
| Article | Year |
|---|---|
Long-term renal function and hypertension in adult survivors of childhood sarcoma: Single center experience.
Topics: Adolescent; Adult; Antineoplastic Agents, Alkylating; Body Mass Index; Child; Child, Preschool; Cros | 2018 |